About this product
The label lists 450 mg of Boswellia extract and 125 mg of devil’s claw extract, with duplicate source lines for both botanicals. The pairing creates a focused joint-comfort formula with apparently meaningful botanical amounts.
The ingredient breadth may support several related pathways, but a longer formula also makes dose quality and overlap more important. Suitability depends on wanting the complete combination rather than one collection ingredient alone.
Duplicate entries make actual totals ambiguous, and neither boswellic acids, AKBA, nor devil’s-claw active markers are disclosed. The 60-serving vegcap supply should therefore be judged by active-form clarity and suitability, not just the listed botanical weight.
Pros
Combines two joint-focused botanicals Listed extract amounts appear meaningful Serving value is reasonable
Cons
Duplicate ingredient lines make actual totals unclear. Boswellic-acid, AKBA, and devil’s-claw active markers are absent. No enhanced-delivery method is listed. The formula focuses on comfort rather than cartilage or lubrication support.
Warnings
Boswellia and devil’s claw may add to bleeding tendency with anticoagulant or antiplatelet medicines. The duplicate botanical entries should be clarified before combining this with another Boswellia or devil’s-claw product. People sensitive to either Boswellia or devil’s claw cannot adjust the two botanical amounts independently.
